The human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts

Journal of Virology

Volumn 85, Issue 10, 2011, Pages 4841-4852

  Perng, Yi Chieh ^a   Qian, Zhikang ^a   Fehr, Anthony R ^a   Xuan, Baoqin ^a   Yu, Dong ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FKBP12 PROTEIN; HEMAGGLUTININ; LIGAND; PROTEIN; SHIELD 1; UL79 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA REPLICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NEWBORN; NONHUMAN; OPEN READING FRAME; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STABILITY; SKIN FIBROBLAST; STOP CODON; UL79 GENE; VIRUS GENE; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CELL LINE; CYTOMEGALOVIRUS; GENE DELETION; GENES, ESSENTIAL; HUMANS; MUTAGENESIS, INSERTIONAL; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 79955384525     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02344-10     Document Type: Article

References (67)

1. Ahn, J. H., W. J. Jang, and G. S. Hayward. 1999. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol. 73:10458-10471.
2. Arumugaswami, V., et al. 2006. ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J. Virol. 80:9730-9740.
3. Banaszynski, L. A., L. C. Chen, L. A. Maynard-Smith, A. G. Ooi, and T. J. Wandless. 2006. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126:995-1004.
4. Borst, E. M., G. Hahn, U. H. Koszinowski, and M. Messerle. 1999. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73:8320-8329.
5. Brady, J., J. B. Bolen, M. Radonovich, N. Salzman, and G. Khoury. 1984. Stimulation of simian virus 40 late gene expression by simian virus 40 tumor antigen. Proc. Natl. Acad. Sci. U. S. A. 81:2040-2044.
6. Bresnahan, W. A., and T. E. Shenk. 2000. UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc. Natl. Acad. Sci. U. S. A. 97:14506-14511.
7. Britt, W. J., and C. A. Alford (ed.). 1996. Cytomegalovirus, 3rd ed. Lippin-cott-Raven, Philadelphia, PA.
8. Carrozza, M. J., and N. A. DeLuca. 1996. Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol. Cell. Biol. 16:3085-3093.
9. Chee, M. S., et al. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
10. Crough, T., and R. Khanna. 2009. Immunobiology of human cytomegalovi-rus: from bench to bedside. Clin. Microbiol. Rev. 22:76-98.
11. Davison, A. J., et al. 2003. The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J. Gen. Virol. 84:17-28.
12. Deng, H., J. T. Chu, N. H. Park, and R. Sun. 2004. Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68. J. Virol. 78:9123-9131.
13. Dolan, A., et al. 2004. Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85:1301-1312.
14. Dunn, W., et al. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228.
15. Dunn, W., et al. 2005. Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell. Microbiol. 7:1684-1695.
16. Fehr, A. R., and D. Yu. 2011. Human cytomegalovirus early protein pUL21a promotes efficient viral DNA synthesis and the late accumulation of immediate-early transcripts. J. Virol. 85:663-674.
17. Fehr, A. R., and D. Yu. 2010. Human cytomegalovirus gene UL21a encodes a short-lived cytoplasmic protein and facilitates virus replication in fibro-blasts. J. Virol. 84:291-302.
18. Fortunato, E. A., and D. H. Spector. 1998. p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomeg-alovirus. J. Virol. 72:2033-2039.
19. Gao, M., and D. M. Knipe. 1991. Potential role for herpes simplex virus ICP8 DNA replication protein in stimulation of late gene expression. J. Virol. 65:2666-2675.
20. Glass, M., A. Busche, K. Wagner, M. Messerle, and E. M. Borst. 2009. Conditional and reversible disruption of essential herpesvirus proteins. Nat. Methods 6:577-579.
21. Grattan, M. T., et al. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561-3566.
22. Grey, F., et al. 2005. Identification and characterization of human cytomeg-alovirus-encoded microRNAs. J. Virol. 79:12095-12099.
23. Iftode, C., and S. J. Flint. 2004. Viral DNA synthesis-dependent titration of a cellular repressor activates transcription of the human adenovirus type 2 IVa2 gene. Proc. Natl. Acad. Sci. U. S. A. 101:17831-17836.
24. Isomura, H., et al. 2005. Two Sp1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication. J. Virol. 79:9597-9607.
25. Isomura, H., T. Tsurumi, and M. F. Stinski. 2004. Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication. J. Virol. 78:12788-12799.
26. Johnson, P. A., and R. D. Everett. 1986. The control of herpes simplex virus type-1 late gene transcription: a 'TATA-box'/cap site region is sufficient for fully efficient regulated activity. Nucleic Acids Res. 14:8247-8264.
27. Keller, J. M., and J. C. Alwine. 1984. Activation of the SV40 late promoter: direct effects of T antigen in the absence of viral DNA replication. Cell 36:381-389.
28. Kim, D. B., S. Zabierowski, and N. A. DeLuca. 2002. The initiator element in a herpes simplex virus type 1 late-gene promoter enhances activation by ICP4, resulting in abundant late-gene expression. J. Virol. 76:1548-1558.
29. Kinsella, T. M., and G. P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413.
30. Kuvin, J. T., and C. D. Kimmelstiel. 1999. Infectious causes of atherosclerosis. Am. Heart J. 137:216-226.
31. Lu, M., and T. Shenk. 1999. Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J. Virol. 73:676-683.
32. Luo, M. H., K. Rosenke, K. Czornak, and E. A. Fortunato. 2007. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)-and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 81:1934-1950.
33. Martinez-Guzman, D., et al. 2003. Transcription program of murine gammaherpesvirus 68. J. Virol. 77:10488-10503.
34. Mavromara-Nazos, P., and B. Roizman. 1987. Activation of herpes simplex virus 1 gamma 2 genes by viral DNA replication. Virology 161:593-598.
35. Meier, J. L., M. J. Keller, and J. J. McCoy. 2002. Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication. J. Virol. 76:313- 326.
36. Meier, J. L., and J. A. Pruessner. 2000. The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression. J. Virol. 74:1602-1613.
37. Melnick, J. L., E. Adam, and M. E. Debakey. 1993. Cytomegalovirus and atherosclerosis. Eur. Heart J. 14(Suppl. K):30-38.
38. Mitchell, D. P., J. P. Savaryn, N. J. Moorman, T. Shenk, and S. S. Terhune. 2009. Human cytomegalovirus UL28 and UL29 open reading frames encode a spliced mRNA and stimulate accumulation of immediate-early RNAs. J. Virol. 83:10187-10197.
39. Mocarski, E. S., and C. T. Courcelle (ed.). 2001. Cytomegaloviruses and their replication, 4th ed., vol. 2. Lippincott-Raven, Philadelphia, PA.
40. Morris, S. J., and K. N. Leppard. 2009. Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression. J. Virol. 83:3049-3058.
41. Muhlestein, J. B., et al. 2000. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 102:1917-1923.
42. Murphy, E., I. Rigoutsos, T. Shibuya, and T. E. Shenk. 2003. Reevaluation of human cytomegalovirus coding potential. Proc. Natl. Acad. Sci. U. S. A. 100:13585-13590.
43. Murphy, E., et al. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 100:14976-14981.
44. Penfold, M. E., and E. S. Mocarski. 1997. Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology 239:46-61.
45. Qian, Z., V. Leung-Pineda, B. Xuan, H. Piwnica-Worms, and D. Yu. 2010. Human cytomegalovirus protein pUL117 targets the mini-chromosome maintenance complex and suppresses the cellular DNA synthesis. PLoS Pathogens 6:e1000814.
46. Qian, Z., B. Xuan, T. T. Hong, and D. Yu. 2008. The full-length protein encoded by human cytomegalovirus gene UL117 is required for the proper maturation of viral replication compartments. J. Virol. 82:3452-3465.
47. Rice, S. A., and D. M. Knipe. 1990. Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J. Virol. 64:1704-1715.
48. Silva, M. C., Q. C. Yu, L. Enquist, and T. Shenk. 2003. Human cytomega-lovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J. Virol. 77:10594-10605.
49. Speir, E., et al. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
50. Stinski, M. F. 1978. Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides. J. Virol. 26:686- 701.
51. Streblow, D. N., S. L. Orloff, and J. A. Nelson. 2001. Do pathogens accelerate atherosclerosis? J. Nutr. 131:2798S-2804S.
52. Terhune, S., et al. 2007. Human cytomegalovirus UL38 protein blocks apop-tosis. J. Virol. 81:3109-3123.
53. Thomas, G. P., and M. B. Mathews. 1980. DNA replication and the early to late transition in adenovirus infection. Cell 22:523-533.
54. Toth, M., W. Doerfler, and T. Shenk. 1992. Adenovirus DNA replication facilitates binding of the MLTF/USF transcription factor to the viral major late promoter within infected cells. Nucleic Acids Res. 20:5143-5148.
55. Varnum, S. M., et al. 2004. Identification of proteins in human cytomegalo-virus (HCMV) particles: the HCMV proteome. J. Virol. 78:10960-10966.
56. Warming, S., N. Costantino, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36.
57. White, E. A., C. L. Clark, V. Sanchez, and D. H. Spector. 2004. Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J. Virol. 78:1817-1830.
58. Wiley, S. R., et al. 1993. SV40 early-to-late switch involves titration of cellular transcriptional repressors. Genes Dev. 7:2206-2219.
59. Winkler, M., and T. Stamminger. 1996. A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles. J. Virol. 70:8984-8987.
60. Wong, E., T. T. Wu, N. Reyes, H. Deng, and R. Sun. 2007. Murine gamma-herpesvirus 68 open reading frame 24 is required for late gene expression after DNA replication. J. Virol. 81:6761-6764.
61. Wu, T. T., et al. 2009. ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J. Virol. 83:2265-2273.
62. Xuan, B., Z. Qian, E. Torigoi, and D. Yu. 2009. Human cytomegalovirus protein pUL38 induces ATF4 expression, inhibits persistent JNK phosphor-ylation, and suppresses endoplasmic reticulum stress-induced cell death. J. Virol. 83:3463-3474.
63. Yu, D., M. C. Silva, and T. Shenk. 2003. Functional map of human cyto-megalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U. S. A. 100:12396-12401.
64. Yu, D., G. A. Smith, L. W. Enquist, and T. Shenk. 2002. Construction of a self-excisable bacterial artificial chromosome containing the human cyto-megalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 76:2316-2328.
65. Zhou, C., and D. M. Knipe. 2002. Association of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme. J. Virol. 76:5893-5904.
66. Zhou, Y. F., et al. 1996. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 335:624-630.
67. Zuo, F., and J. E. Mertz. 1995. Simian virus 40 late gene expression is regulated by members of the steroid/thyroid hormone receptor superfamily. Proc. Natl. Acad. Sci. U. S. A. 92:8586-8590.